^
Association details:
| Biomarker: | PDSS1 overexpression |
|---|---|
| Cancer: | Hepatocellular Cancer |
| Drug Class: | Immunotherapy |
| Direction: | Resistant |
Evidence:
Source:
Title:
Decaprenyl Diphosphate Synthase Subunit 1 (PDSS1): A Potential Prognostic Biomarker and Immunotherapy-Target for Hepatocellular Carcinoma
Published date:
05/03/2022
Excerpt:
We attempted to determine the role of PDSS1 in predicting the survival and efficacy of immunotherapy for HCC patients….Patients with higher PDSS1 expression had shorter overall survival and relapse-free survival.
DOI:
https://doi.org/10.2147/CMAR.S364346